{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:58:58Z","timestamp":1768726738379,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["82073013"],"award-info":[{"award-number":["82073013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81801862"],"award-info":[{"award-number":["81801862"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["82073016"],"award-info":[{"award-number":["82073016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["ZXYXZ-2019011"],"award-info":[{"award-number":["ZXYXZ-2019011"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Photodynamic therapy (PDT) has been strongly recommended as an excellent alternative treatment for Bowen disease (BD). However, reported data on 5-aminolaevulinic acid-mediated PDT (ALA-PDT) with red-light irradiation are limited and the long-term effectiveness remains to be determined, especially in dark-skinned populations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to review routine clinical practice in the field of BD treatment with ALA-PDT over an extended study period (2011\u20132021), calculate the overall clearance rate, and explore and evaluate factors that might affect the effectiveness of therapy in a real-world setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The medical records of patients with BD who received ALA-PDT with red-light irradiation between February 2011 and June 2021 were reviewed and summarized. Univariate and multivariate analyses of clinically relevant variables that may affect treatment outcomes were conducted to identify risk predictors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The overall clearance rate of 122 BD lesions was 89.3% with a median follow-up time of 36\u2005months. The correlation between the effectiveness and fluorescence intensity of pre-PDT or PDT sessions was statistically significant after eliminating the interference of confounding factors. All recurrences occurred in the first 2\u2005years following ALA-PDT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ALA-PDT is an effective treatment for BD in patients with darker-coloured skin. Well-executed operations and effective pretreatment are the determinants of effectiveness. Fluorescence intensity of pre-PDT appeared to be a significant predictor of final effectiveness. In addition, 2\u2005years of follow-up is necessary following ALA-PDT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llae139","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T02:42:06Z","timestamp":1713580926000},"page":"1190-1196","source":"Crossref","is-referenced-by-count":3,"title":["Real-world data of 5-aminolaevulinic acid-mediated photodynamic therapy for Bowen disease: a 10-year retrospective study in patients with darker-coloured skin (2011\u20132021)"],"prefix":"10.1093","volume":"49","author":[{"given":"Shan","family":"Fang","sequence":"first","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiru","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caihe","family":"Liao","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongxia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorong","family":"Yan","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhao","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiping","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-1274","authenticated-orcid":false,"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"2024091818145220700_llae139-B1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.12766","article-title":"British Association of Dermatologists\u2019 guidelines for the management of squamous cell carcinoma in situ (Bowen\u2019s disease) 2014","volume":"170","author":"Morton","year":"2014","journal-title":"Br J Dermatol"},{"key":"2024091818145220700_llae139-B2","first-page":"33","article-title":"Clinical, histological and therapeutic features of Bowen\u2019s disease","volume":"58","author":"Neagu","year":"2017","journal-title":"Rom J Morphol Embryol"},{"key":"2024091818145220700_llae139-B3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archderm.1961.01580160087015","article-title":"An association between Bowen\u2019s disease and internal cancer","volume":"84","author":"Peterka","year":"1961","journal-title":"Arch Dermatol"},{"key":"2024091818145220700_llae139-B4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.1986.01660220042010","article-title":"Carcinoma arising in Bowen\u2019s disease","volume":"122","author":"Kao","year":"1986","journal-title":"Arch Dermatol"},{"key":"2024091818145220700_llae139-B5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0303-6987.2006.00516.x","article-title":"Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification \u2013 part two","volume":"33","author":"Cassarino","year":"2006","journal-title":"J Cutan Pathol"},{"key":"2024091818145220700_llae139-B6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pdpdt.2018.09.009","article-title":"Photodynamic therapy for Bowen\u2019s disease (squamous cell carcinoma in situ) current review and update","volume":"24","author":"O\u2019Connell","year":"2018","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2024091818145220700_llae139-B7","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jdv.16017","article-title":"European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications\u00a0\u2013 actinic keratoses, Bowen\u2019s disease and basal cell carcinomas","volume":"33","author":"Morton","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"2024091818145220700_llae139-B8","doi-asserted-by":"crossref","first-page":"102340","DOI":"10.1016\/j.pdpdt.2021.102340","article-title":"Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition)","volume":"35","author":"Shi","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2024091818145220700_llae139-B9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/jdv.14164","article-title":"Effectiveness of photodynamic therapy in Bowen\u2019s disease: a retrospective observational study in 423 lesions","volume":"31","author":"Zaar","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024091818145220700_llae139-B10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jdv.13558","article-title":"Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers","volume":"30","author":"Tarstedt","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024091818145220700_llae139-B11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2340\/00015555-1068","article-title":"Fluorescence diagnostics of basal cell carcinomas comparing methyl-aminolaevulinate and aminolaevulinic acid and correlation with visual clinical tumour size","volume":"91","author":"Sandberg","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"2024091818145220700_llae139-B12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2133.2009.09437.x","article-title":"Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema","volume":"161","author":"Mikolajewska","year":"2009","journal-title":"Br J Dermatol"},{"key":"2024091818145220700_llae139-B13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"key":"2024091818145220700_llae139-B14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"key":"2024091818145220700_llae139-B15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5021\/ad.2020.32.1.47","article-title":"Comparison of the treatment outcomes of photodynamic therapy and ingenol mebutate in Bowen\u2019s disease: a retrospective observational study","volume":"32","author":"An","year":"2020","journal-title":"Ann Dermatol"},{"key":"2024091818145220700_llae139-B16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jaad.2021.07.067","article-title":"Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: a systematic review and meta-analysis","volume":"87","author":"Stewart","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2024091818145220700_llae139-B17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5021\/ad.2014.26.3.321","article-title":"Comparative study of photodynamic therapy with topical methyl aminolevulinate versus 5-\u00adaminolevulinic acid for facial actinic keratosis with long-term follow-up","volume":"26","author":"Ko","year":"2014","journal-title":"Ann Dermatol"},{"key":"2024091818145220700_llae139-B18","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"2024091818145220700_llae139-B19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/DSS.0000000000000800","article-title":"Photodynamic therapy: a clinical consensus guide","volume":"42","author":"Ozog","year":"2016","journal-title":"Dermatol Surg"},{"key":"2024091818145220700_llae139-B20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/phpp.12453","article-title":"Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen\u2019s disease in clinical practice: a retrospective cohort study (2006\u20132017)","volume":"35","author":"Aguilar-Bernier","year":"2019","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2024091818145220700_llae139-B21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjd.17309","article-title":"British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018","volume":"180","author":"Wong","year":"2019","journal-title":"Br J Dermatol"},{"key":"2024091818145220700_llae139-B22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pdpdt.2016.06.012","article-title":"Plum-blossom needling promoted PpIX fluorescence intensity from 5-aminolevulinic acid in porcine skin model and patients with actinic keratosis","volume":"15","author":"Chen","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2024091818145220700_llae139-B23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","article-title":"Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma","volume":"80","author":"Keyal","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024091818145220700_llae139-B24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ad.2009.12.003","article-title":"[Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis]","volume":"101","author":"Fern\u00e1ndez-Guarino","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"2024091818145220700_llae139-B25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0001-7310(08)74958-5","article-title":"[Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging]","volume":"99","author":"Fern\u00e1ndez-Guarino","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"2024091818145220700_llae139-B26","doi-asserted-by":"crossref","first-page":"849248","DOI":"10.1155\/2014\/849248","article-title":"Six years of experience in photodynamic therapy for basal cell carcinoma: results and fluorescence diagnosis from 191 lesions","volume":"2014","author":"Fern\u00e1ndez-Guarino","year":"2014","journal-title":"J Skin Cancer"},{"key":"2024091818145220700_llae139-B27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jdv.12064","article-title":"Fluorescence diagnosis and photodynamic therapy for Bowen\u2019s disease treatment","volume":"28","author":"Truchuelo","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024091818145220700_llae139-B28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pdpdt.2013.05.001","article-title":"Huge Bowen\u2019s disease: a pitfall of topical photodynamic therapy","volume":"10","author":"Park","year":"2013","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2024091818145220700_llae139-B29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaad.2019.10.079","article-title":"Photodynamic therapy for cutaneous squamous cell carcinoma in situ: impact of anatomic location, tumor diameter, and incubation time on effectiveness","volume":"82","author":"Kibbi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024091818145220700_llae139-B30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/09546634.2011.590789","article-title":"Photodynamic therapy in the treatment of extensive Bowen\u2019s disease","volume":"23","author":"Lopez","year":"2012","journal-title":"J\u00a0Dermatolog Treat"},{"key":"2024091818145220700_llae139-B31","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1524-4725.2012.02507.x","article-title":"Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery","volume":"38","author":"Chuang","year":"2012","journal-title":"Dermatol Surg"},{"key":"2024091818145220700_llae139-B32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/ijd.12867","article-title":"Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth\u2013Hitchcock experience","volume":"54","author":"Knackstedt","year":"2015","journal-title":"Int J Dermatol"},{"key":"2024091818145220700_llae139-B33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/DSS.0000000000001400","article-title":"Factors influencing squamous cell carcinoma in situ recurrence and implications for treatment choice","volume":"44","author":"Matsumoto","year":"2018","journal-title":"Dermatol Surg"},{"key":"2024091818145220700_llae139-B34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2340\/00015555-2330","article-title":"Squamous cell carcinoma following photodynamic therapy for cutaneous Bowen\u2019s disease in a series of 105 patients","volume":"96","author":"Ratour-Bigot","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"2024091818145220700_llae139-B35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1684\/ejd.2017.3131","article-title":"Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy","volume":"27","author":"Gracia Cazana","year":"2017","journal-title":"Eur J Dermatol"},{"key":"2024091818145220700_llae139-B36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1365-2133.2011.10265.x","article-title":"Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites","volume":"164","author":"Tyrrell","year":"2011","journal-title":"Br J Dermatol"},{"key":"2024091818145220700_llae139-B37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.1996.tb04011.x","article-title":"Bowen\u2019s disease: statistical study of a 10\u2005year period","volume":"23","author":"Kovacs","year":"1996","journal-title":"J Dermatol"},{"key":"2024091818145220700_llae139-B38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0781.2010.00507.x","article-title":"Photodynamic therapy in dermatology: state-of-the-art","volume":"26","author":"Babilas","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae139\/58341535\/llae139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/10\/1190\/59183666\/llae139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/10\/1190\/59183666\/llae139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:15:03Z","timestamp":1726683303000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/10\/1190\/7654048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,4,20]]},"published-print":{"date-parts":[[2024,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae139","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,4,20]]}}}